R Squared Ltd Takes Position in Corteva, Inc. $CTVA

R Squared Ltd bought a new stake in Corteva, Inc. (NYSE:CTVA) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 6,561 shares of the company’s stock, valued at approximately $444,000.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CTVA. Activest Wealth Management lifted its position in shares of Corteva by 118.3% in the 3rd quarter. Activest Wealth Management now owns 369 shares of the company’s stock worth $25,000 after acquiring an additional 200 shares during the period. True Wealth Design LLC raised its stake in shares of Corteva by 209.5% in the third quarter. True Wealth Design LLC now owns 390 shares of the company’s stock valued at $26,000 after purchasing an additional 264 shares in the last quarter. Total Investment Management Inc. acquired a new position in shares of Corteva in the second quarter valued at $27,000. Twin Peaks Wealth Advisors LLC bought a new position in Corteva in the second quarter worth $29,000. Finally, Redmont Wealth Advisors LLC acquired a new stake in Corteva during the third quarter worth $29,000. 81.54% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Brian Titus sold 8,311 shares of the company’s stock in a transaction dated Friday, February 20th. The shares were sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider owned 8,090 shares in the company, valued at $619,289.50. This represents a 50.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. 0.14% of the stock is owned by corporate insiders.

Corteva Stock Performance

NYSE:CTVA opened at $80.01 on Friday. Corteva, Inc. has a 1 year low of $53.40 and a 1 year high of $80.23. The firm has a 50 day moving average of $71.91 and a 200-day moving average of $68.83. The company has a current ratio of 1.43, a quick ratio of 0.96 and a debt-to-equity ratio of 0.07. The stock has a market capitalization of $53.81 billion, a P/E ratio of 50.64, a price-to-earnings-growth ratio of 2.69 and a beta of 0.75.

Corteva (NYSE:CTVA) last released its quarterly earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, hitting analysts’ consensus estimates of $0.22. Corteva had a return on equity of 9.06% and a net margin of 6.29%.The business had revenue of $3.91 billion for the quarter, compared to analyst estimates of $4.23 billion. During the same period in the prior year, the company earned $0.32 EPS. Corteva’s revenue for the quarter was down 1.7% on a year-over-year basis. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. As a group, sell-side analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 16th. Investors of record on Monday, March 2nd will be issued a $0.18 dividend. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date of this dividend is Monday, March 2nd. Corteva’s payout ratio is currently 45.57%.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the stock. CICC Research increased their price objective on shares of Corteva from $70.00 to $80.00 and gave the company an “outperform” rating in a research note on Wednesday, February 11th. Oppenheimer set a $86.00 price target on shares of Corteva in a research report on Thursday, February 5th. JPMorgan Chase & Co. cut shares of Corteva from an “overweight” rating to a “neutral” rating and raised their price target for the stock from $75.00 to $77.00 in a research note on Thursday, February 5th. Zacks Research lowered Corteva from a “strong-buy” rating to a “hold” rating in a research note on Friday, February 20th. Finally, Deutsche Bank Aktiengesellschaft raised their target price on Corteva from $85.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, February 5th. One analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have assigned a Hold rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $82.30.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.